Messenger Bio offers end-to-end services for RNA medicine discovery, providing custom mRNA synthesis and lipid nanoparticle (LNP) formulation. Their platform accelerates R&D by optimizing mRNA constructs for stability and expression, and delivering ready-to-transfect products for rapid preclinical evaluation.
Funding
Funding not disclosed
Founders
Product
Problem
Developing novel RNA therapeutics and vaccines requires efficient and reliable methods for mRNA design, synthesis, and delivery. Researchers often face challenges in optimizing mRNA constructs for stability and expression, as well as in developing effective lipid nanoparticle (LNP) formulations for preclinical evaluation. This can lead to extended development timelines and increased research costs.
Solution
Messenger Bio provides a comprehensive suite of services for RNA medicine discovery, encompassing custom mRNA synthesis and LNP formulation. Their platform offers end-to-end solutions from initial construct design and optimization through to in vitro screening and in vivo pharmacology studies. By leveraging proprietary algorithms for sequence optimization and advanced LNP formulation techniques, Messenger Bio accelerates the research and development process for RNA-based therapeutics and vaccines. They deliver ready-to-transfect mRNA products and optimized delivery systems, enabling researchers to rapidly assess construct performance and advance their projects.
Target Audience
The primary customers are academic research institutions, biotechnology companies, and pharmaceutical organizations engaged in the discovery and development of mRNA-based therapeutics, vaccines, and gene editing technologies.
Features
- Custom mRNA synthesis with proprietary coding sequence optimization algorithms for enhanced translation efficiency and stability.
- Optimization of 5' and 3' untranslated regions (UTRs) for improved _in vitro_ and _in vivo_ performance.
- Incorporation of modified nucleotides (e.g., N1-methylpseudouridine) to reduce immunogenicity and enhance translation.
- Advanced purification methods to remove dsRNA contaminants, ensuring high purity and reduced immunogenicity.
- Flexible production scales from micrograms to milligrams for preclinical research needs.
- Lipid nanoparticle (LNP) formulation services for efficient _in vitro_ and _in vivo_ RNA delivery.
- Integrated _in vitro_ screening platform for high-throughput evaluation of mRNA construct performance, including thermal stability and expression analysis.
- _In vivo_ pharmacology services for preclinical assessment of mRNA formulation efficacy and safety.
- ShipRight™ mRNA shipping solution for maintaining mRNA integrity at room temperature during global transit.